article thumbnail

Redi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One Platform

Healthcare IT Today

This results in a non-adherence rate of approximately 70%, resulting in an estimated annual revenue loss of $637 billion for the pharmaceutical industry. Redi Health bridges the gap between consumer technology and clinical health and support, connecting Pharma, providers, and patients in one platform.

article thumbnail

New Company, Velsera, Represents Summa Equity’s Vision to Improve Global Health Outcomes

Healthcare IT Today

He has 30+ years of business experience, with 20 years in the healthcare and pharmaceutical industries. Gavin was most recently CEO of the global Medical Imaging and eClincial company Calyx, a spinout from Parexel.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology

Healthcare IT Today

The participant’s digital twin forecasts their health outcomes under placebo, regardless of their actual assignment. TwinRCTs reduce the time it takes to bring new drugs and therapies to market, ultimately paving the way for improved health outcomes for all. Founder and CEO at Unlearn.

article thumbnail

How pharmaceutical marketing affects decisions about patient care

Kaiser Permanente

In 2016, the 12 largest pharmaceutical companies spent more than $120 billion on marketing , compared to $75 billion on research and development. While some marketing tactics are well known, the following provides more detail on some of the lesser-known tactics that the pharmaceutical industry uses.

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

global lead of the Accenture Life Sciences business, said, “Through our investment in QuantHealth, we are further solidifying our commitment to utilizing advanced technologies to bring revolutionary change in the pharmaceutical industry. Petra Jantzer, Ph.D.,

article thumbnail

Can Artificial Intelligence Replicate The Human Touch in Healthcare Provision?

HIT Consultant

AI also has the potential to identify, and even design, up to 50 new therapeutic drugs in the next decade, representing a $ 50 billion opportunity for the global pharmaceutical industry, with a 20-40% reduction in pre-clinical costs.

article thumbnail

Create Health Ventures Launches $21M Fund to Invest in Digital Health Startups

HIT Consultant

Create Health Ventures aims to support startups developing these solutions by providing capital, mentorship, and strategic guidance. Additionally, the pharmaceutical industry’s increased focus on clinical trials presents a substantial opportunity for digital health solutions.